Alexander Maxwell
Value, growth, long-term horizon, biotech

Tekmira Pharmaceuticals: An Interesting Long-Term Investment

Tekmira Pharmaceuticals (TKMR) is a small-cap pharmaceutical company with a very interesting pipeline. The company has many different drugs in many stages of development. As these drugs progress, so too should the stock price at Tekmira. Tekmira represents a very nice mix of medium- to long-term catalysts that should help to drive shareholder growth over the next few years.


The company has a multitude of very interesting products in its pipeline.

(click to enlarge)

As you can see, most of the drugs in the pipeline are in the early stages of development.

There are many different, promising development programs in Tekmira's pipeline, however, four are highlighted below. Each of these programs have the potential to help drive long term...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details